Antimalarial drug resistance in the Eastern Mediterranean Region
AbstractStudies done between 1997 and 2003 are reviewed to give an overall picture of antimalarial drug resistance in the Eastern Mediterranean Region of the World Health Organization [WHO]. The situation in 8 countries where resistance has been reported is detailed. It has been difficult to abandon chloroquine as first-line treatment even though resistance to it is widespread. Resistance to sulfadoxine-pyrimethamine has also been detected. The spread of resistance could be slowed down by the adoption of effective national policies and control programmes. Coordination between counties and with other WHO regions, as opposed to working in isolation, could further reduce the spread of resistance
Abdel Hameed, A.A. (2003). Antimalarial drug resistance in the Eastern Mediterranean Region. http://www.who.int/iris/handle/10665/119301
EMHJ - Eastern Mediterranean Health Journal, 9 (4), 492-508, 2003
MetadataShow full item record
Showing items related by title and MeSH subject.
Informal Consultation on Monitoring Resistance to Antimalarial Drugs in the Mekong Region (Cambodia, China, Lao People's Democratic Republic, Myanmar, Thailand, Vietnam), Phnom Penh,Cambodia, 16-17 October 2000 : report World Health Organization. Regional Office for the Western Pacific ((WP)MVP/ICP/MVP/002-E, 2000)